Xi Tan

11PUBLICATIONS

20CO-AUTHORS

Molecular targetsNutrigenomics and personalised nutritionPharmacogenomicsTraditional Chinese medicine and treatmentsDisease surveillance

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|May 20, 2026

Predicting Treatment Failure With Sodium-Glucose Cotransporter-2 Inhibitors in People With Type 2 Diabetes: Novel Artificial Intelligence and Machine Learning Approach.

|Apr 30, 2026

Cardiometabolic and Renal Outcomes in Semaglutide Users with Type 2 Diabetes Achieving Glycemic and Weight Goals: An Observational Cohort Study.

|Jan 09, 2026

Comparison of cardiovascular outcomes between once-weekly semaglutide and dulaglutide in adults with type 2 diabetes and established atherosclerotic cardiovascular disease in the United States.

Xi Tan, Yuanjie Liang, Lin Xie

|May 16, 2025

Healthcare Resource Utilization and Costs in Individuals Who Discontinue Liraglutide and Who Switch from Liraglutide to Once-Weekly Injectable Semaglutide.

Xi Tan, Brenna L Brady, Lin Xie

|May 09, 2025

Macrovascular and microvascular complications in US Medicare enrollees with type 2 diabetes with and without atherosclerotic cardiovascular disease.

Tyler J Dunn, Xi Tan, Joanna Harton

|Oct 10, 2024

Comparing Machine Learning and Advanced Methods with Traditional Methods to Generate Weights in Inverse Probability of Treatment Weighting: The INFORM Study.

Doyoung Kwak, Yuanjie Liang, Xu Shi

Pageof 2

Frequent Collaborators

Kamlesh Khunti

Swapnil Rajpathak

Miao Yu

Boshu Ru

Yu Liu

Kartik Kannapur

Dheepan Ramanan

Garin Kessler

Dominik Lautsch

Gregg Fonarow

Frequent Collaborators

Kamlesh Khunti

Swapnil Rajpathak

Miao Yu

Boshu Ru